CollabRx, Inc. (NASDAQ: CLRX) today announces that Dr. Gavin Gordon, CollabRx Head of Business Development & Alliances, will participate as an invited speaker in the annual conference of the Oregon Bioscience Association to be held on October 9 th and 10 th at Marylhurst University.
The conference, titled “Bioscience Digitization and Discovery,” brings together industry authorities to discuss current topics impacting healthcare-related digital innovation. A key focus of the conference is how digital technology is producing widespread and significant changes in the healthcare industry. This shift is due to the emergence of wireless, mobile, and IT-related solutions being developed in response to the $300 billion value-added “big data” opportunity in the US health care market (as reported by McKinsey Global Institute). A large part of this market opportunity specifically targets areas in cancer and cancer genomics.
In his presentation, Dr. Gordon will discuss CollabRx’s cloud-based expert systems that inform healthcare decision-making by aggregating and contextualizing the world’s knowledge on molecular medicine with specific insights from the nation’s top clinical experts. These types of digital laboratory tools and techniques are critical in providing a clinically relevant framework to the massive quantities of tumor genetic data being produced (i.e., “big data”). Providing this interpretation at the point of care is increasingly becoming an important part of the clinical management of cancer patients.
At the conference Dr. Gordon will provide additional details on CollabRx’s recently announced partnership with Life Technologies to provide informatics-based solutions to physicians to aid in their interpretation of broad molecular panels and cancer diagnostics being developed by Life Technologies. Dr. Gordon will also give a live demonstration of the Therapy Finder™ tool, a web-based expert system developed by CollabRx that serves as a common platform for both patients and physicians to encourage shared decision-making. A version of the Therapy Finder™ is being made broadly available online via a recently announced partnership with MedPage Today, Everyday Health, Inc.’s physician portal that serves 96% of all oncologists and 1.6 million monthly online unique users.